AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Cellectar Biosciences, Inc. Director's Dealing 2023

Mar 16, 2023

35021_dirs_2023-03-16_afa5191b-af9c-4610-932c-e9f0f2b4774e.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2023-02-15

Reporting Person: Shustov Andrei (Senior Vice President, Medical)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	7181.7	Direct